Tcr2 Therapeutics Inc
Biotechnology
Healthcare
TCRR
38.62 M shares
NASDAQ US
traded
30 May 2023
listed
yes
open
1.62
52 week high
3.75
high
1.62
52 week low
1.32
previous Close
1.58
P/E ratio
market cap
60.83 M
div yield
0
net incoming
-30.59 M
3.19 %
net profit margin
-3059400000.00 %
0.00 %
operating incoming
-31.10 M
2.10 %
net change in cash
9.80 M
132.75 %
cash on hand
54.01 M
22.16 %
top